Business Context and Reporting Period
Company: PMGC Holdings Inc. (Nasdaq: ELAB)
Filing Type: Form 8-K (Current Report)
Date of Report: September 18, 2026
Reporting Period: Event-based report regarding a specific corporate transaction.
Key Financial Metrics
This filing does not provide specific financial statements, revenue figures, profit margins, cash flow data, debt levels, or liquidity metrics. The report focuses on a contractual agreement rather than periodic financial performance.
Material Changes and Events
- Payment Agreement Executed: On September 18, 2026, PMGC Holdings Inc. and its wholly owned subsidiary, NorthStrive Biosciences Inc., entered into a payment agreement with Longevity Health Holdings, Inc.
- Subject of Agreement: The agreement secures royalty payments owed to PMGC in connection with the sale of its Elevai Skincare business, which occurred in January 2025.
- Regulatory Disclosure: The event was disclosed under Item 7.01 (Regulation FD Disclosure) and accompanied by a press release (Exhibit 99.1).
Guidance, Outlook, and Risks
The filing text does not contain forward-looking guidance, management commentary on future outlook, specific risk factors, or details on contingencies beyond the execution of the payment agreement. The document explicitly states that the information furnished is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the terms of the payment agreement with Longevity Health Holdings, Inc. by reviewing the attached press release (Exhibit 99.1).
- Confirm the status of royalty collections from the January 2025 Elevai Skincare business sale.
- Review subsequent filings for any impact of this agreement on the company's cash flow or receivables.